Novack Rachel, Zhang Lewei, Hoang Lynn N, Kadhim Mohamad, Ng Tony L, Poh Catherine F, Kevin Ko Yen Chen
Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada; Department of Laboratory Medicine and Pathology, BC Oral Biopsy Service, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Mod Pathol. 2023 Jul;36(7):100153. doi: 10.1016/j.modpat.2023.100153. Epub 2023 Mar 9.
The diagnosis of oral epithelial dysplasia is based on the degree of architectural and cytologic atypia in the squamous epithelium. The conventional grading system of mild, moderate, and severe dysplasia is considered by many the gold standard in predicting the risk of malignant transformation. Unfortunately, some low-grade lesions, with or without dysplasia, progress to squamous cell carcinoma (SCC) in short periods. As a result, we are proposing a new approach to characterize oral dysplastic lesions that will help identify lesions at high risk for malignant transformation. We included a total of 203 cases of oral epithelial dysplasia, proliferative verrucous leukoplakia, lichenoid, and commonly observed mucosal reactive lesions to evaluate their p53 immunohistochemical (IHC) staining patterns. We identified 4 wild-type patterns, including scattered basal, patchy basal/parabasal, null-like/basal sparing, mid-epithelial/basal sparing, and 3 abnormal p53 patterns, including overexpression basal/parabasal only, overexpression basal/parabasal to diffuse, and null. All cases of lichenoid and reactive lesions exhibited scattered basal or patchy basal/parabasal patterns, whereas human papillomavirus-associated oral epithelial dysplasia demonstrated null-like/basal sparing or mid-epithelial/basal sparing patterns. Of the oral epithelial dysplasia cases, 42.5% (51/120) demonstrated an abnormal p53 IHC pattern. p53 abnormal oral epithelial dysplasia was significantly more likely to progress to invasive SCC when compared to p53 wild-type oral epithelial dysplasia (21.6% vs 0%, P < .0001). Furthermore, p53 abnormal oral epithelial dysplasia was more likely to have dyskeratosis and/or acantholysis (98.0% vs 43.5%, P < .0001). We propose the term p53 abnormal oral epithelial dysplasia to highlight the importance of utilizing p53 IHC stain to recognize lesions that are at high risk of progression to invasive disease, irrespective of the histologic grade, and propose that these lesions should not be graded using the conventional grading system to avoid delayed management.
口腔上皮发育异常的诊断基于鳞状上皮的结构和细胞异型程度。许多人认为传统的轻度、中度和重度发育异常分级系统是预测恶性转化风险的金标准。不幸的是,一些低级别病变,无论有无发育异常,都在短时间内进展为鳞状细胞癌(SCC)。因此,我们提出一种新的方法来表征口腔发育异常病变,这将有助于识别具有恶性转化高风险的病变。我们总共纳入了203例口腔上皮发育异常、增殖性疣状白斑、苔藓样病变以及常见的黏膜反应性病变,以评估它们的p53免疫组织化学(IHC)染色模式。我们识别出4种野生型模式,包括散在基底型、斑片状基底/基底旁型、无表达样/基底保留型、上皮中层/基底保留型,以及3种异常p53模式,包括仅基底/基底旁型过表达、基底/基底旁型过表达至弥漫性过表达、无表达型。所有苔藓样病变和反应性病变病例均表现为散在基底型或斑片状基底/基底旁型模式,而人乳头瘤病毒相关的口腔上皮发育异常表现为无表达样/基底保留型或上皮中层/基底保留型模式。在口腔上皮发育异常病例中,42.5%(51/120)表现出异常的p53 IHC模式。与p53野生型口腔上皮发育异常相比,p53异常的口腔上皮发育异常进展为浸润性SCC的可能性显著更高(21.6%对0%,P < .0001)。此外,p53异常的口腔上皮发育异常更可能出现角化不良和/或棘层松解(98.0%对43.5%,P < .0001)。我们提出“p53异常口腔上皮发育异常”这一术语,以强调利用p53 IHC染色来识别进展为浸润性疾病高风险病变的重要性,无论其组织学分级如何,并建议不应使用传统分级系统对这些病变进行分级,以避免延误治疗。